Holly Fernandez Lynch writes, “Nevertheless, even the upswing still leaves quite a bit of the glass empty: Results from more than 1 in 4 trials have still not been properly reported. The ethical consequences are substantial, and the government should be using its considerable enforcement authority to put an end to it. But it isn’t.”

Quick Read

The US is sitting on one of the largest data sets on any animal group, but most of it is inaccessible and restricted to local agencies

Quick Read

Vice President Joe Biden’s effort to encourage faster cancer cures was one factor leading to announcement

Quick Read

Safety First

February 24, 2016

Nature Eds.: It is worrying that US government departments are unable to divulge basic data on research projects involving human subjects. Such data should be publicly available to ensure volunteers’ safety

Quick Read

No benefit can be derived from trials which are either invisible or reported partially or selectively. To avoid this risk, a growing number of organisations have made efforts to allow access to clinical trial results in a detail hitherto unknown. Despite the growing international effort and a notable legislative effort in the EU, the US lags behind

Quick Read